| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 Dec 24 | ANTX AN2 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 9,816 | 0.00 | 135,015 |
| 27 Nov 24 | ANTX AN2 Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.4 | 2,000 | 2.80 k | 125,199 |
| 19 Nov 24 | ANTX AN2 Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.01 | 5,000 | 5.05 k | 123,199 |
| 18 Nov 24 | ANTX AN2 Therapeutics | Common Stock | Buy | Acquire P | No | No | 0.9998 | 20,000 | 20.00 k | 118,199 |
| 19 Jun 24 | ANTX AN2 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2 | 64,503 | 129.01 k | 64,503 |
| 6 Feb 24 | CYT Cyteir Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 1.69 | 14,150 | 23.91 k | 227,439 |
| 6 Feb 24 | CYT Cyteir Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.69 | 14,150 | 23.91 k | 0 |
